Business
Currency:USD
2024/Q3
Stock NameRevenueRatio
Oncology164.92M30.92%
Metabolic124.73M23.39%
Other107.37M20.13%
Cardiology55.81M10.47%
Central Nervous System42.1M7.89%
Antiviral and Anti-infective (AVAI)38.38M7.20%
View all
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States1.85B98.00%
North America, Europe, Asia, South America, Africa and Australia37.72M2.00%
